We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Radio frequency identification (RFID) product tags have long been touted as a panacea for the problem of counterfeit and gray market drugs, but other technologies — both familiar and new — can also offer protection, according to specialists at a recent industry convention.
Wyeth has achieved a remarkably rapid conversion from paper records to a mostly electronic data capture (EDC) system in its clinical trials, a transformation the company hopes to complete by 2007.
The Artelon DRU Spacer, a device for treating osteoarthritis in the distal radioulnar joint in the wrist, has received the CE Mark to market the product in the EU, biomaterials company Artimplant announced.
China’s pharmaceutical market totaled roughly $19.2 billion in 2005, according to a new study that forecasts the country will become the fifth-largest pharmaceutical market by the end of the decade and the world’s largest market by 2050.
The pharmaceutical industry is nearing wide adoption of electronic data capture (EDC) over paper trials, but there is still much work ahead for individual firms in adopting the more efficient system, experts say.
Pharma giant Wyeth is now using electronic data capture (EDC) in roughly 80 percent of its clinical trials -- with a goal of 90 percent by the end of 2007, according to a company project leader.